Australia markets closed

Abiomed, Inc. (ABMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
251.88-2.73 (-1.07%)
At close: 4:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2021)Next year (2022)
No. of analysts9979
Avg. Estimate1.161.224.385.07
Low estimate1.011.013.854
High estimate1.541.565.346.08
Year ago EPS1.510.74.434.38
Revenue estimateCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2021)Next year (2022)
No. of analysts7799
Avg. Estimate232.55M233.81M843.95M1.01B
Low estimate225.49M221.26M821.36M950.61M
High estimate245.78M251.03M891.3M1.1B
Year ago salesN/A206.66M840.88M843.95M
Sales growth (year/est)N/A13.10%0.40%19.80%
Earnings history30/12/201930/03/202029/06/202029/09/2020
Est. EPS1.090.940.290.92
Actual EPS1.510.70.981.36
Difference0.42-0.240.690.44
Surprise %38.50%-25.50%237.90%47.80%
EPS trendCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2021)Next year (2022)
Current estimate1.161.224.385.07
7 days ago1.21.274.425.29
30 days ago1.21.274.425.29
60 days ago1.181.234.485.29
90 days ago1.141.193.354.77
EPS revisionsCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/A1
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1113
Growth estimatesABMDIndustrySector(s)S&P 500
Current qtr.-23.20%N/AN/AN/A
Next qtr.74.30%N/AN/AN/A
Current year-1.10%N/AN/AN/A
Next year15.80%N/AN/AN/A
Next 5 years (per annum)24.00%N/AN/AN/A
Past 5 years (per annum)60.37%N/AN/AN/A